Prevention of hepatocellular carcinoma

Clin Liver Dis. 2005 May;9(2):329-46, viii. doi: 10.1016/j.cld.2004.12.008.

Abstract

The accuracy and the reliability of well-recognized clinical, virologic, histologic, and molecular risk factors for hepatocellular carcinoma are still insufficient; thus, accurate risk prediction of developing cancer in individual patients remains an elusive goal.

Publication types

  • Comparative Study
  • Review

MeSH terms

  • Antiviral Agents / therapeutic use
  • Carcinoma, Hepatocellular / prevention & control*
  • Female
  • Hepatitis B, Chronic / drug therapy*
  • Hepatitis C, Chronic / drug therapy*
  • Humans
  • Interferons / therapeutic use
  • Liver Cirrhosis / prevention & control
  • Liver Neoplasms / prevention & control*
  • Male
  • Mass Screening / methods
  • Primary Prevention / methods*
  • Prognosis
  • Randomized Controlled Trials as Topic
  • Risk Assessment
  • Sensitivity and Specificity
  • Survival Analysis

Substances

  • Antiviral Agents
  • Interferons